glp-1 litigation news Alarming rise in weight loss drug overdoses Study flags need to monitor

Randomized, double-blind, placebo-controlled trial of oral docusate in the management of constipation in hospice patients

39 Conventional risk factors for diabetic gastroparesis include a long duration of diabetes, presence of other microvascular complications, smoking, obesity and female sex

Gala GLP-1's platform connects patients with licensed providers who independently evaluate whether compounded GLP-1/GIP or a brand-name FDA-approved alternative is appropriate for each individual case

A comparative analysis by Bozorgi et al

I 2 = 24%)

Mood improvement was initially observed in diabetic patients treated with GLP1RA